KLA Corporation Operating Cash Flow decreased by 0.3% to $1.16B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 16.7%, from $995.24M to $1.16B. Over 4 years (FY 2021 to FY 2025), Operating Cash Flow shows an upward trend with a 16.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase indicates strong operational efficiency and cash generation, while a decrease may signal operational challenges or issues with working capital management.
This metric represents the total cash generated or consumed by a company's core business operations during a specific pe...
Standard across all industries; peers in the medical device and diagnostics sector typically maintain high conversion ratios of net income to operating cash flow.
net_cash_from_operating| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $465.62M | $863.80M | $836.04M | $793.64M | $819.23M | $1.01B | $494.44M | $1.20B | $959.12M | $883.74M | $961.01M | $571.21M | $892.62M | $995.24M | $1.53B | $387.71M | $1.16B | $1.16B |
| QoQ Change | — | +85.5% | -3.2% | -5.1% | +3.2% | +23.5% | -51.1% | +143.7% | -20.4% | -7.9% | +8.7% | -40.6% | +56.3% | +11.5% | +54.1% | -74.7% | +200.5% | -0.3% |
| YoY Change | — | — | — | — | +75.9% | +17.1% | -40.9% | +51.8% | +17.1% | -12.6% | +94.4% | -52.6% | -6.9% | +12.6% | +59.6% | -32.1% | +30.5% | +16.7% |